Active Ingredient: Risperidone Injection:
Bipolar disorder: As monotherapy or as adjunctive therapy to lithium or valproate for the maintenance treatment of bipolar I disorder.
Schizophrenia: Treatment of schizophrenia.
Oral:
Bipolar mania:
Monotherapy: For the treatment of acute manic or mixed episodes associated with bipolar I disorder in adults and in children and adolescents 10 to 17 years of age.
Adjunctive therapy: As adjunctive therapy with lithium or valproate for the treatment of adults with acute manic or mixed episodes associated with bipolar I disorder.
Irritability associated with autistic disorder: For the treatment of irritability associated with autistic disorder in children and adolescents 5 to 17 years of age, including symptoms of aggression toward others, deliberate self-injuriousness, temper tantrums, and quickly changing moods.
Schizophrenia: For the treatment of schizophrenia in adults and adolescents 13 to 17 years of age.